EQT 10-Q report for 2025-06-30

EQT reported strong first‑half 2025 results driven by commodity sales and derivative gains. Six‑month operating revenues were $4,297,569; net income attributable to EQT Corporation was $1,026,286; diluted EPS for six months was $1.70. Cash and cash equivalents were $555,492 at June 30, 2025. Total assets were $39,666,748 and total equity was $25,097,850.

This Ticker Thesis documents EQT Corporation’s Form 10‑Q for the quarter ended June 30, 2025. The filing contains unaudited condensed consolidated financial statements and accompanying notes. Key reported items from the filing: three‑ and six‑month operating revenues of $2,557,719 and $4,297,569 respectively; net income attributable to EQT of $784,147 for the quarter and $1,026,286 for the six‑month period; diluted EPS of $1.30 (quarter) and $1.70 (six months); cash and cash equivalents of $555,492 as of June 30, 2025; total assets of $39,666,748; total liabilities of $14,568,898; and total equity of $25,097,850. The document also includes the table of contents, MD&A signposts, and notes (e.g., segment reporting change to three segments). The play status is marked as failed/expired with a recommended strategy of sell — that label reflects the play metadata and not an analysis-derived trading recommendation. The filing itself is primary-source disclosure; use the full 10‑Q (notes, MD&A and risk factors) for any actionable investment decision.

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026 contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.